| ATRI Description: Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells fluid delivery devices, and ophthalmic and cardiovascular products for medical applications in the United States, Canada, and internationally. The company’s fluid delivery products include valves that promote infection control and needle safety, as well as for use in intubation, intravenous, catheter, and other applications in anesthesia and oncology areas. Its cardiovascular products include MPS2 myocardial protection system that delivers fluids and medications, and mixes drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels in invasive surgical procedures; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products that are used in heart bypass surgery. The company’s ophthalmic products comprise specialized medical devices that help in contact lens disinfection; and a line of balloon catheters that are used for the treatment of nasolacrimal duct obstruction in children and adults. It also manufactures instrumentation and associated disposables, which measures the activated clotting time of blood; and a line of products designed for safe needle and scalpel blade containment. In addition, the company produces inflation systems and valves primarily for use in marine and aviation safety products; one-way and two-way pressure relief valves that protect electronics and munitions during transportation, as well as for use in other medical and non-medical applications; and components that are used in survival products. Atrion Corporation sells its products to physicians, hospitals, clinics, and other treatment centers, as well as other equipment manufacturers through direct sales personnel, independent sales representatives, and distributors. The company was founded in 1944 and is headquartered in Allen, Texas. |
